Melinta Therapeutics, LLC v. Nexus Pharmaceuticals, Inc.
| MELINTA THERAPEUTICS, LLC, MELINTA SUBSIDIARY CORP. and REMPEX PHARMACEUTICALS, INC. |
| NEXUS PHARMACEUTICALS, INC. |
| 25-1281 |
| December 13, 2024 |
| U.S. Court of Appeals, Federal Circuit |
| Patent - (ANDA) (Fed. Qst.) |
Opinions
We have the following opinions for this case:
| Description |
|---|
| MELINTA THERAPEUTICS, LLC v. NEXUS PHARMACEUTICALS, INC. |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 24, 2025. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 11 Note to File: The following cases are consolidated: 25-1281 Lead with 25-1282 Member Case. The parties must file all documents in the lead appeal only. [1063219] [25-1281, 25-1282] [IMH] [Entered: 01/24/2025 09:53 AM] |
Filing 10
ORDER consolidating appeals (25-1281 with 25-1282). Appellant's opening brief is due 02/11/2025. Service as of this date by the Clerk of Court. [1063216] [25-1281, 25-1282] [IMH] [Entered: 01/24/2025 09:52 AM]
|
| Filing 9 Notice of Related Case Information for Appellees Melinta Subsidiary Corp., Melinta Therapeutics, LLC and Rempex Pharmaceuticals, Inc.. Service: 12/27/2024 by email. [1057266] [25-1281] [Damien Dombrowski] [Entered: 12/27/2024 01:27 PM] |
| Filing 8 Docketing Statement for the Appellees Melinta Subsidiary Corp., Melinta Therapeutics, LLC and Rempex Pharmaceuticals, Inc.. Service: 12/27/2024 by email. [1057265] [25-1281] [Damien Dombrowski] [Entered: 12/27/2024 01:25 PM] |
| Filing 7 Certificate of Interest for Appellees Melinta Subsidiary Corp., Melinta Therapeutics, LLC and Rempex Pharmaceuticals, Inc.. Service: 12/27/2024 by email. [1057263] [25-1281] [Damien Dombrowski] [Entered: 12/27/2024 01:23 PM] |
| Filing 6 Entry of Appearance for Dominick Conde; Damien Dombrowski; Ha Kung Wong; Monica Chou as counsel for Appellees Melinta Subsidiary Corp., Melinta Therapeutics, LLC and Rempex Pharmaceuticals, Inc.. Service: 12/27/2024 by email. [1057260] [25-1281] [Damien Dombrowski] [Entered: 12/27/2024 01:21 PM] |
| Filing 5 Docketing Statement for the Appellant Nexus Pharmaceuticals, Inc.. Service: 12/20/2024 by email. [1056244] [25-1281] [Helen Ji] [Entered: 12/20/2024 10:19 PM] |
| Filing 4 Notice of Related Case Information for Appellant Nexus Pharmaceuticals, Inc.. Service: 12/20/2024 by email. [1056243] [25-1281] [Helen Ji] [Entered: 12/20/2024 10:18 PM] |
| Filing 3 Certificate of Interest for Appellant Nexus Pharmaceuticals, Inc.. Service: 12/20/2024 by email. [1056242] [25-1281] [Helen Ji] [Entered: 12/20/2024 10:17 PM] |
| Filing 2 Entry of Appearance for Imron T. Aly; Kevin M. Nelson; Helen H. Ji; Matthew T. Wilkerson as counsel for Appellant Nexus Pharmaceuticals, Inc.. Service: 12/20/2024 by email. [1056241] [25-1281] [Helen Ji] [Entered: 12/20/2024 10:16 PM] |
| Filing 1 Appeal docketed. Received: 12/10/2024. [1054182] Entry of Appearance is due on 12/27/2024. Certificate of Interest is due on 12/27/2024. Docketing Statement is due on 12/27/2024. Appellant's brief is due on 02/11/2025. [IMH] [Entered: 12/13/2024 02:34 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
